Inhibition of guinea-pig lymphocyte activation by histamine and histamine analogues.
1 The incorporation of [3H]-thymidine into guinea-pig lymphocytes stimulated by a plant lectin (concanavalin A), soluble antigen (tuberculin (P.P.D.)) and syngeneic hepatoma cells, was partially inhibited (50%) by histamine in vitro. 2 The effect of histamine on both mitogen and antigen dose-response curves suggests a non-competitive, probably physiological antagonism. 3 The inhibitory dose range of histamine lay between 10 nM and 30 microM with an ID50 of approximately 400 nM. 4 The potency order for histamine analogues for the inhibition of lymphocyte activation was histamine greater than or equal to 4-methylhistamine greater than 2-methylhistamine greater than 3-methylhistamine. This is in accord with the mediation of the response through an H2-receptor. 5 H2-receptor antagonists reversed the inhibitory effect of histamine in a dose-related manner, but both metiamide and burimamide, in high concentrations, augmented lymphocyte activation in their own right. This precluded the determination of affinity constants and made it impossible to state with certainty that the inhibition of lymphocyte activation by histamine was mediated by an H2-receptor.
D000818:Animals; D000941:Antigens; D002049:Burimamide / Q000494:pharmacology; D003208:Concanavalin A / Q000494:pharmacology; D003864:Depression, Chemical; D006168:Guinea Pigs; D006632:Histamine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D066298:In Vitro Techniques; D008114:Liver Neoplasms, Experimental / Q000378:metabolism; D008213:Lymphocyte Activation / Q000187:drug effects*; D008785:Metiamide / Q000494:pharmacology; D008934:Mitogens / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism
D000941:Antigens; D008934:Mitogens; D003208:Concanavalin A; D008785:Metiamide; D006632:Histamine; D002049:Burimamide; D013936:Thymidine